Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
Operating Income Contraction
Strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-89.15M
Near historical average
Average (6y)
$-81.25M
Historical baseline
Range
High:$-13.66M
Low:$-128.32M
CAGR
+36.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-89.15M | -1.2% |
| 2023 | $-88.13M | +9.7% |
| 2022 | $-97.58M | +24.0% |
| 2021 | $-128.32M | -31.2% |
| 2020 | $-97.83M | -81.0% |
| 2019 | $-54.04M | -295.6% |
| 2018 | $-13.66M | - |